Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.21.73 (
urokinase-type plasminogen activator
)
10,685
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We studied the relationship between differentiation, transformation, and
uPA
production in a system of rat thyroid cells in vitro. The fully differentiated FRTL5 cells did not produce detectable amounts of
uPA
, even after stimulation with phorbol esters, potent inducers of
uPA
expression. All the other cell lines (i.e., FRT, cells which have lost the characteristics of the differentiated thyroid cells; 1-5 G and
FRA
, transformed cells derived from rat thyroid tumors) produced
uPA
, the 1-5 G line being the highest producer. Also the FRTL line became positive for
uPA
production after viral transformation (clone KM4). The lack of
uPA
expression in FRTL5 cells was not due to the presence of inhibitors and these cells did not produce an inactive molecule, as shown by immunoprecipitation with anti-
uPA
antibody. However, in FRTL5 cells Northern analysis showed the presence of a small amount of
uPA
-specific mRNA that increased appreciably after phorbol ester stimulation. In conclusion, in our system
uPA
expression was a property of undifferentiated and transformed cells; in fully differentiated cells
uPA
expression was switched off by a still unclear mechanism.
...
PMID:Production of urokinase-type plasminogen activator by normal and transformed rat thyroid cells in culture. 254 Oct 4